VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 51 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $692,783 | +23.1% | 95,032 | 0.0% | 0.00% | – |
Q1 2024 | $562,589 | -19.1% | 95,032 | 0.0% | 0.00% | – |
Q4 2023 | $695,634 | +88.4% | 95,032 | 0.0% | 0.00% | – |
Q3 2023 | $369,199 | -32.7% | 95,032 | 0.0% | 0.00% | – |
Q2 2023 | $548,335 | +98.0% | 95,032 | +189.8% | 0.00% | – |
Q1 2022 | $277,000 | -6.7% | 32,788 | 0.0% | 0.00% | – |
Q4 2021 | $297,000 | -25.6% | 32,788 | 0.0% | 0.00% | – |
Q3 2021 | $399,000 | +7.5% | 32,788 | 0.0% | 0.00% | – |
Q2 2021 | $371,000 | -25.4% | 32,788 | 0.0% | 0.00% | – |
Q1 2021 | $497,000 | -8.3% | 32,788 | -30.3% | 0.00% | – |
Q4 2020 | $542,000 | +51.4% | 47,054 | +1.7% | 0.00% | – |
Q3 2020 | $358,000 | -23.2% | 46,263 | +9.4% | 0.00% | – |
Q2 2020 | $466,000 | -15.3% | 42,307 | -16.0% | 0.00% | – |
Q1 2020 | $550,000 | -25.2% | 50,373 | +8.9% | 0.00% | – |
Q4 2019 | $735,000 | +13.8% | 46,265 | +5.7% | 0.00% | – |
Q3 2019 | $646,000 | +178.4% | 43,755 | +118.9% | 0.00% | – |
Q2 2019 | $232,000 | – | 19,989 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 62,882 | $512,000 | 1.42% |
Diag Capital Management, LP | 114,947 | $937,000 | 1.07% |
Perceptive Advisors | 3,410,412 | $27,794,000 | 1.06% |
Fosun International Ltd | 794,279 | $6,473,000 | 0.39% |
Orbimed Advisors | 1,479,733 | $12,060,000 | 0.22% |
PURA VIDA INVESTMENTS, LLC | 63,916 | $521,000 | 0.10% |
SPHERA FUNDS MANAGEMENT LTD. | 97,000 | $791,000 | 0.09% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 327,420 | $2,668,000 | 0.05% |
Capital Investment Advisory Services, LLC | 12,400 | $101,000 | 0.04% |
CONNING INC. | 129,013 | $1,051,000 | 0.04% |